AmyCScheflerMD

Ophthalmology • Houston, TX

Retinal Disease, Ocular Oncology

Retina Consultants of Texas

Join to view full profile

Dr. Schefler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schefler's full profile

Already have an account?

Office
6560 Fannin Street
750
Houston, TX 77030
Phone+1 713-524-3434

Fax+1 713-524-3220

Education & Training

University of Miami/Jackson Health System/Bascom Palmer Eye InstituteChief Residency, Ophthalmology, 2009 - 2010
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2004 - 2007
Olive View/UCLA Medical CenterInternship, Internal Medicine, 2003 - 2004
Weill Cornell MedicineClass of 2003

Certifications & Licensure

TX State Medical License 2012 - 2026
FL State Medical License 2007 - 2014
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Intravitreal Aflibercept Injection for Radiation Retinopathy Start of enrollment: 2012 Nov 01
Completed
Phase 1
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
Completed
Phase 4
New Biopsy Technique for Uveal Melanoma Start of enrollment: 2013 Jun 01
Completed
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma Start of enrollment: 2013 Jul 01
Active, not recruiting
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
Completed
Phase 1, Phase 2
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Start of enrollment: 2014 Sep 23
Completed
Phase 2
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial Start of enrollment: 2017 Jul 05
Active, not recruiting
Phase 2
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma Start of enrollment: 2020 Aug 05
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Unilateral Multiple Choroidal Melanomas within an Area of Amelanotic Congenital Ocular Melanosis.
Henry C Skrehot, Amer F Alsoudi, Amy C Schefler
Ophthalmology. Retina. 2024-12-01
Multifocal Retinocytoma Associated With Intronic Acceptor Splice Site Variants in the RB1 Gene.
Jennifer Li-Wang, Patricia Chévez-Barrios, Jessica S Thomas, Amy C Schefler
Cureus. 2024-10-01
2 citations
15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).
J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01

Authored Content

Randomized Trial of Monthly Versus as-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1 Year OutcomesApril 2020

Press Mentions

Aura Biosciences Presents New Preclinical AU-011 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual MeetingMay 3rd, 2021
Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at the American Academy of Ophthalmology 2019 Annual MeetingFebruary 24th, 2020
Light-Activated Agent Novel Option for Uveal MelanomaJanuary 15th, 2020
Join now to see all

Professional Memberships

American College of Surgeons - ACS
Member